-transparent.png){kind=logo}
Synthetic LHRH was given intravenously in a dose of 250 mug to a group of 7 normal women in different phases of the menstrual cycle. The LH response was more pronounced in the preovulatory and luteal phase than in the follicular phase of the cycle. The FSH response was less than that of LH and was the same in all phases of the cycle. No significant changes were observed in the plasma levels of estradiol 17-beta, progesterone, or testosterone for up to 6 hours as well as 24 hours after LHRH administration in any of the subjects studied. In 2 of 3 subjects, administration of LHRH in the luteal phase resulted in the prolongation of the cycle. No effect on cycle length was observed when LHRH was given at other times of the cycle. LHRH did not affect the length of the subsequent cycle regardless of the day of administration.
S C Stone, and
R P Dickey, and
A J Kastin, and
A V Schally
July 1995,
The Journal of reproductive medicine,
S C Stone, and
R P Dickey, and
A J Kastin, and
A V Schally
March 1978,
Clinical endocrinology,
S C Stone, and
R P Dickey, and
A J Kastin, and
A V Schally
January 1991,
The Journal of clinical endocrinology and metabolism,
S C Stone, and
R P Dickey, and
A J Kastin, and
A V Schally
February 1980,
L'union medicale du Canada,
S C Stone, and
R P Dickey, and
A J Kastin, and
A V Schally
June 1983,
Clinical chemistry,
S C Stone, and
R P Dickey, and
A J Kastin, and
A V Schally
October 1987,
Life sciences,
S C Stone, and
R P Dickey, and
A J Kastin, and
A V Schally
April 1975,
Endocrinology,
S C Stone, and
R P Dickey, and
A J Kastin, and
A V Schally
July 1979,
The Journal of clinical endocrinology and metabolism,
S C Stone, and
R P Dickey, and
A J Kastin, and
A V Schally
January 1981,
Journal of endocrinological investigation,
S C Stone, and
R P Dickey, and
A J Kastin, and
A V Schally
January 1990,
Clinical endocrinology,
